BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

565 related articles for article (PubMed ID: 15727113)

  • 1. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
    Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
    MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The use of antidepressants to treat depression in children and adolescents].
    Desombre H; Paccalin C; Revol O; Fourneret P
    Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
    Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
    Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.
    Bradley AJ; Lenox-Smith AJ
    J Psychopharmacol; 2013 Aug; 27(8):740-58. PubMed ID: 23832963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of antidepressants currently used to treat anxiety disorders.
    Feighner JP
    J Clin Psychiatry; 1999; 60 Suppl 22():18-22. PubMed ID: 10634351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective serotonin reuptake inhibitors in mixed anxiety-depression.
    Berk M
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S41-5. PubMed ID: 11110018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clomipramine and other serotonin reuptake inhibitors in the treatment of depressed mood, anxiety and impaired impulse control].
    Eriksson E
    Psychiatr Pol; 1994; 28(5):601-12. PubMed ID: 7991713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anxiety and depression: which antidepressants treat both at the same time?].
    Laflamme F
    Perspect Infirm; 2010; 7(2):43. PubMed ID: 21744603
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can recovery from depression be achieved?
    Shelton RC; Tomarken AJ
    Psychiatr Serv; 2001 Nov; 52(11):1469-78. PubMed ID: 11684742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.
    Strawn JR; Dobson ET; Giles LL
    Curr Probl Pediatr Adolesc Health Care; 2017 Jan; 47(1):3-14. PubMed ID: 28043839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.
    Luft MJ; Lamy M; DelBello MP; McNamara RK; Strawn JR
    Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):50-62. PubMed ID: 29358037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of patients with depression associated with anxiety symptoms.
    Nutt D
    J Clin Psychiatry; 1997; 58 Suppl 8():11-6. PubMed ID: 9236730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy in depressed children and adolescents.
    Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C
    World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating comorbid depression and anxiety.
    Kuzel RJ
    J Fam Pract; 1996 Dec; 43(6 Suppl):S45-53. PubMed ID: 8969712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of selective serotonin reuptake inhibitors in the treatment of psychiatric disorders.
    Nutt DJ; Forshall S; Bell C; Rich A; Sandford J; Nash J; Argyropoulos S
    Eur Neuropsychopharmacol; 1999 Jul; 9 Suppl 3():S81-6. PubMed ID: 10523062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of new antidepressants in the treatment of anxiety/depressive disorders.
    Boerner RJ; Möller HJ
    Pharmacopsychiatry; 1999 Jul; 32(4):119-26. PubMed ID: 10505481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Selective serotonin reuptake inhibitors and newer antidepressive substances in child and adolescent psychiatry].
    Heiser P; Remschmidt H
    Z Kinder Jugendpsychiatr Psychother; 2002 Aug; 30(3):173-83. PubMed ID: 12227220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are SSRIs really more effective for anxious depression?
    Panzer MJ
    Ann Clin Psychiatry; 2005; 17(1):23-9. PubMed ID: 15941028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.